Your shopping cart is empty!
Your Partner in Proteomics™
View all pathways
View all interactive pathways
+ Add More..
Fig.1: Expression analysis of DR-4. Anti-DR4 antibody (Clone: ABM1B11) was tested at 2 µg/ml on K562 lysate.
Roll over image to zoom in
Order now and get it on Tuesday April 24, 2018
Same day delivery FREE on San Diego area orders placed by 1.00 PM
View San Diego delivery areas
Same-day delivery in San Diego available for the following zip codes:
Available Pack Size(s)
Add to Cart
Death receptor 4 (DR4) or TRAIL-R1, a member of the tumor necrosis factor receptor superfamily, is a cell surface receptor that triggers the apoptotic machinery upon binding to its ligand tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). DR4 is expressed in most of human tissues including spleen, peripheral blood leukocytes, small intestine and thymus. DR4 expression is enhanced by DNA damage whether induced by ionizing radiation or by chemotherapeutic agents. On binding DR4, TRAIL induces cell death via caspase-dependent apoptosis. DR4 mediate oligomeric Abeta induction of extrinsic apoptotic pathways in human microvascular cerebral endothelial cells with activation of both caspase-8 and caspase-9. It is considered a promising molecular target for cancer therapy.
Western blot analysis: 2-4 µg/ml, FACS analysis- 0.5-1 µg/10^6 Cells
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
Polyclonal antibody to NALP4 (PAN-2)
Polyclonal Antibody to BCL-XL(Phospho-Ser62)
Monoclonal Antibody to p73 (Clone: ABM13D1)
Monoclonal Antibody to Mouse PD-1 (29F.1A12)
Monoclonal antibody to Troponin 1 (Clone: ABM5A65)
Monoclonal Antibody to human CTLA-4 (Clone:BN13)
Can't read the image? click here to refresh.
Tel : 858-263-4982
Fax : 858-205-1192
Email : firstname.lastname@example.org
Connect with Us